Cargando…

Measuring patient-reported outcomes in advanced gastric cancer

BACKGROUND: Gastric cancer (GC), one of the most common cancers in the world, is often diagnosed at an advanced stage and associated with a poor prognosis. Quality of life and patient-reported outcomes (PROs) are important considerations when treating GC patients. The aim of this study was to identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jianming, Evans, TR Jeffry, Coon, Cheryl, Copley-Merriman, Kati, Su, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776644/ https://www.ncbi.nlm.nih.gov/pubmed/24062809 http://dx.doi.org/10.3332/ecancer.2013.351

Ejemplares similares

Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union
por: Clark, Marci J, et al.
Publicado: (2014)

Patient experiences with oily skin: The qualitative development of content for two new patient reported outcome questionnaires
por: Arbuckle, Robert, et al.
Publicado: (2008)

A Review and Characterization of the Various Perceptions of Quality Cancer Care
por: Colosia, Ann D, et al.
Publicado: (2011)

The insulin-like growth factor system and its receptors: A potential novel anticancer target
por: Lindsay, Colin R, et al.
Publicado: (2008)

Direct costs associated with adverse events of systemic therapies for advanced melanoma: Systematic literature review
por: Copley-Merriman, Catherine, et al.
Publicado: (2018)

Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study
por: Mordin, Margaret, et al.
Publicado: (2014)

Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
por: Conway, James RW, et al.
Publicado: (2019)

Antiproliferative effect of exemestane in lung cancer cells
por: Koutras, Angelos, et al.
Publicado: (2009)

Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee in the United States: A Systematic Review of Economic Evaluations
por: Mordin, Margaret, et al.
Publicado: (2021)

Assessment of patient-reported outcome measures in the surgical treatment of patients with gastric cancer
por: Straatman, Jennifer, et al.
Publicado: (2015)

Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
por: Propper, David, et al.
Publicado: (2016)

Effect of the degree of gastric filling on the measured thickness of advanced gastric cancer by computed tomography
por: Yang, Li, et al.
Publicado: (2018)

High burden and unmet patient needs in chronic kidney disease
por: Braun, LeeAnn, et al.
Publicado: (2012)

Early Gastric Cancer-Like Advanced Gastric Cancer versus Advanced Gastric Cancer-Like Early Gastric Cancer
por: Park, Hyun Sik, et al.
Publicado: (2013)

Cardiac tamponade due to advanced gastric cancer: case report and review: Cardiac tamponade due to advanced gastric cancer
por: Mansilla, Sofía, et al.
Publicado: (2021)

Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology
por: Bektas, Meryem, et al.
Publicado: (2020)

Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs
por: Bektas, Meryem, et al.
Publicado: (2020)

Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease
por: Bektas, Meryem, et al.
Publicado: (2020)

A Case of Gastric Tuberculosis Mimicking Advanced Gastric Cancer
por: Kim, Seong-Eun, et al.
Publicado: (2006)

Advances in translational therapy for locally advanced gastric cancer
por: Zhao, Kai, et al.
Publicado: (2023)

Clinical Outcome of Palliative Radiotherapy for Locally Advanced Symptomatic Gastric Cancer in the Modern Era
por: Tey, Jeremy, et al.
Publicado: (2014)

GC-PROM: validation of a patient-reported outcomes measure for Chinese patients with gastric cancer
por: Hu, Xiaojuan, et al.
Publicado: (2020)

Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review
por: Copley-Merriman, Catherine, et al.
Publicado: (2021)

Advances in Patient-Reported Outcomes: The NIH PROMIS(®) Measures
por: Broderick, Joan E., et al.
Publicado: (2013)

Early gastric cancer mimicking advanced gastric cancer.
por: Kitamura, K., et al.
Publicado: (1997)

A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours
por: Wilson, Richard H, et al.
Publicado: (2017)

Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer
por: Lee, Sung Ryol, et al.
Publicado: (2011)

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer
por: Barrows, Stephanie M, et al.
Publicado: (2019)

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
por: Wang, Yan, et al.
Publicado: (2019)

Large gastric hamartomatous inverted polyp accompanied by advanced gastric cancer: A case report
por: Park, Gyerim, et al.
Publicado: (2023)

Comparative outcomes between totally laparoscopic total gastrectomy with the modified overlap method for early gastric cancer and advanced gastric cancer: review of 149 consecutive cases
por: Choi, Minha, et al.
Publicado: (2020)

The progress of targeted therapy in advanced gastric cancer
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

Advances in Treatment Models of Advanced Gastric Cancer
por: Li, Tao, et al.
Publicado: (2022)

Recent advances in gastric cancer
por: Al Dulaimi, David
Publicado: (2014)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures
por: Morris, Christopher, et al.
Publicado: (2015)

Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer
por: Konopka, Kamil, et al.
Publicado: (2022)

The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer
por: Oh, Sung Yong, et al.
Publicado: (2013)

The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review
por: Colosia, Ann D., et al.
Publicado: (2017)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
por: An, Ji Yeong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1irkokirecsugih23bkgb044pt